Top

Published in:

01-04-2017 | Letter to the Editor

What Is a Favourable Risk-Benefit Profile Concerning Metabolic Surgery for Patients with Type 2 Diabetes?

Author: Michel Gagner

Published in: Obesity Surgery | Issue 4/2017

Excerpt

I read with interest the article entitled “Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations” by Rubino et al., not only because I think the subject is important but also because I was a delegate during this symposium that took place in London, UK (September 2015) [1]. …

Rubino F, Nathan DM, Eckel RH, et al. Delegates of the 2nd diabetes surgery summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Obes Surg. 2017;27(1):–21.

Gagner M. Effect of sleeve gastrectomy on type 2 diabetes as an alternative to Roux-en-Y gastric bypass: a better long-term strategy. Surg Obes Relat Dis. 2015;11(6):1280–1.CrossRefPubMed

Marceau P, Biron S, Hould FS, et al. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis. 2009;5(1):43–7.CrossRefPubMed

van Dongen JL, Michielsen PP, Van den Eynden GG, et al. Rapidly evolving liver decompensation with some remarkable features 14 years after biliopancreatic derivation: a case report and literature review. Acta Gastroenterol Belg. 2010;73(1):46–51.PubMed

Antal SC. Prevention and reversal of liver damage following biliopancreatic diversion for obesity. Obes Surg. 1994;4(3):285–90.CrossRefPubMed

Adami GF, Friedman D, Cuneo S, et al. Intravenous nutritional support in pregnancy. Experience following biliopancreatic diversion. Clin Nutr. 1992;11(2):106–9.CrossRefPubMed

Gagner M. Bariatric surgery: to bypass or switch? That is the question in obesity surgery. Nat Rev Gastroenterol Hepatol. 2015;12(5):255–6.CrossRefPubMed

Gagner M. Hypoabsorption not malabsorption, hypoabsorptive surgery and not malabsorptive surgery. Obes Surg. 2016;26(11):2783–4.CrossRefPubMed

American Diabetes Association. Obesity Management for the Treatment of Type 2 Diabetes. Diabetes Care 2017 Jan; 40(Supplement 1): S57-S63.

Title: What Is a Favourable Risk-Benefit Profile Concerning Metabolic Surgery for Patients with Type 2 Diabetes?
Author: Michel Gagner
Publication date: 01-04-2017
Publisher: Springer US
Published in: Obesity Surgery / Issue 4/2017
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-017-2566-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

What Is a Favourable Risk-Benefit Profile Concerning Metabolic Surgery for Patients with Type 2 Diabetes?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2017

Laparoscopic Adjustable Gastric Banding: a Prospective Randomized Clinical Trial Comparing 5-Year Results of two Different Bands in 103 Patients

Prior Bariatric Surgery Is Linked to Improved Colorectal Cancer Surgery Outcomes and Costs: A Propensity-Matched Analysis

Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program

QT Interval Shortening After Bariatric Surgery Depends on the Applied Heart Rate Correction Equation

Initial Approach to Childhood Obesity in Spain. A Multisociety Expert Panel Assessment

Erratum to: The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status